Drug development for mitochondrial disease: recent progress, current challenges, and future prospects
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug development for mitochondrial disease: recent progress, current challenges, and future prospects
Authors
Keywords
-
Journal
Expert Opinion on Orphan Drugs
Volume 4, Issue 1, Pages 83-92
Publisher
Informa Healthcare
Online
2015-11-13
DOI
10.1517/21678707.2016.1117972
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic and biochemical intricacy shapes mitochondrial cytopathies
- (2016) Douglass M. Turnbull et al. NEUROBIOLOGY OF DISEASE
- Carvacrol inhibits proliferation and induces apoptosis in human colon cancer cells
- (2015) Kai Fan et al. ANTI-CANCER DRUGS
- Mitochondrial Sirtuins and Their Relationships with Metabolic Disease and Cancer
- (2015) Surinder Kumar et al. ANTIOXIDANTS & REDOX SIGNALING
- An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis
- (2015) Kıvanç Birsoy et al. CELL
- Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells
- (2015) Lucas B. Sullivan et al. CELL
- The link between mitochondrial complex I and brain-derived neurotrophic factor in SH-SY5Y cells – The potential of JNX1001 as a therapeutic agent
- (2015) Helena K. Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Natural Compounds Modulating Mitochondrial Functions
- (2015) Lara Gibellini et al. Evidence-based Complementary and Alternative Medicine
- Polydatin protects hepatocytes against mitochondrial injury in acute severe hemorrhagic shock via SIRT1-SOD2pathway
- (2015) Pengyun Li et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Emerging aspects of treatment in mitochondrial disorders
- (2015) Shamima Rahman JOURNAL OF INHERITED METABOLIC DISEASE
- Mitochondrial Carnitine/Acylcarnitine Translocase: Insights in Structure/ Function Relationships. Basis for Drug Therapy and Side Effects Prediction
- (2015) Annamaria Tonazzi et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders
- (2015) Christin Tischner et al. MITOCHONDRION
- Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome
- (2015) Katrina J. Llewellyn et al. NEUROBIOLOGY OF DISEASE
- The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
- (2015) Alicia M. Pickrell et al. NEURON
- Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer’s Disease
- (2015) Fabian A. Cabezas-Opazo et al. Oxidative Medicine and Cellular Longevity
- Protection against renal ischemia–reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ
- (2015) Anna J. Dare et al. Redox Biology
- Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss
- (2015) Hélène Cwerman-Thibault et al. Molecular Therapy-Methods & Clinical Development
- NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
- (2014) Raffaele Cerutti et al. Cell Metabolism
- Gene therapy for mitochondrial diseases: Leber Hereditary Optic Neuropathy as the first candidate for a clinical trial
- (2014) Hélène Cwerman-Thibault et al. COMPTES RENDUS BIOLOGIES
- Physiological Effect and Therapeutic Application of Alpha Lipoic Acid
- (2014) Sungmi Park et al. CURRENT MEDICINAL CHEMISTRY
- Monitoring Cardiac Function During Idebenone Therapy in Friedreich's Ataxia
- (2014) Di Giovanni et al. CURRENT PHARMACEUTICAL DESIGN
- Editorial (Thematic Issue: Mitochondrial Biogenesis: Pharmacological Approaches)
- (2014) Teresa Valero CURRENT PHARMACEUTICAL DESIGN
- Pioglitazone treatment restoresin vivomuscle oxidative capacity in a rat model of diabetes
- (2014) B. Wessels et al. DIABETES OBESITY & METABOLISM
- Salvaging hope: Is increasing NAD+ a key to treating mitochondrial myopathy?
- (2014) R. N. Lightowlers et al. EMBO Molecular Medicine
- LHON Gene Therapy Vector Prevents Visual Loss and Optic Neuropathy Induced by G11778A Mutant Mitochondrial DNA: Biodistribution and Toxicology Profile
- (2014) R. Koilkonda et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Treatment of Mitochondrial Disorders
- (2014) Gregory M. Enns JOURNAL OF CHILD NEUROLOGY
- Ketogenic diets, mitochondria, and neurological diseases
- (2014) Lindsey B. Gano et al. JOURNAL OF LIPID RESEARCH
- Riboflavin and migraine: the bridge over troubled mitochondria
- (2014) Bruno Colombo et al. NEUROLOGICAL SCIENCES
- The Target of Metformin in Type 2 Diabetes
- (2014) Ele Ferrannini NEW ENGLAND JOURNAL OF MEDICINE
- Thiamine transporter-2 deficiency: outcome and treatment monitoring
- (2014) Juan Ortigoza-Escobar et al. Orphanet Journal of Rare Diseases
- Rosiglitazone Causes Cardiotoxicity via Peroxisome Proliferator-Activated Receptor γ-Independent Mitochondrial Oxidative Stress in Mouse Hearts
- (2014) Huamei He et al. TOXICOLOGICAL SCIENCES
- Increasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular Ascorbate
- (2014) Mark Frederick McCarty et al. Frontiers in Oncology
- Modelling biochemical features of mitochondrial neuropathology
- (2013) Matthew J. Bird et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy
- (2013) T. Klopstock et al. BRAIN
- Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models
- (2013) J C Komen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pioglitazone alleviates the mitochondrial apoptotic pathway and mito-oxidative damage in thed-galactose-induced mouse model
- (2013) Atish Prakash et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Co-enzyme Q10and idebenone use in Friedreich's ataxia
- (2013) Michael H Parkinson et al. JOURNAL OF NEUROCHEMISTRY
- Review of Clinical Trials for Mitochondrial Disorders: 1997–2012
- (2013) Douglas S. Kerr Neurotherapeutics
- Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model
- (2013) R. H. Hamalainen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
- (2013) S. C. Johnson et al. SCIENCE
- Zebrafish as a model system for mitochondrial biology and diseases
- (2013) Shelby L. Steele et al. Translational Research
- Is Leber Hereditary Optic Neuropathy Treatable? Encouraging Results With Idebenone in Both Prospective and Retrospective Trials and An Illustrative Case
- (2012) Esfandiar J. Sabet-Peyman et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Impaired Short-Term Plasticity in Mossy Fiber Synapses Caused by Mitochondrial Dysfunction of Dentate Granule Cells Is the Earliest Synaptic Deficit in a Mouse Model of Alzheimer's Disease
- (2012) S. H. Lee et al. JOURNAL OF NEUROSCIENCE
- RETRACTED: Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy
- (2012) Natalie Noe et al. MITOCHONDRION
- EPI-743 reverses the progression of the pediatric mitochondrial disease—Genetically defined Leigh Syndrome
- (2012) Diego Martinelli et al. MOLECULAR GENETICS AND METABOLISM
- Animal models: Not close enough
- (2012) Jocelyn Rice NATURE
- Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)
- (2011) Sarah J. Lagedrost et al. AMERICAN HEART JOURNAL
- In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
- (2011) Carlo Viscomi et al. Cell Metabolism
- Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study
- (2011) Thomas Meier et al. JOURNAL OF NEUROLOGY
- Pharmacological targeting of mitochondrial complex I deficiency: The cellular level and beyond
- (2011) Peggy Roestenberg et al. MITOCHONDRION
- A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia
- (2010) David R. Lynch et al. ARCHIVES OF NEUROLOGY
- Genetic background influences mitochondrial function: modeling mitochondrial disease for therapeutic development
- (2010) Paule Bénit et al. TRENDS IN MOLECULAR MEDICINE
- Expression of the Ciona intestinalis Alternative Oxidase (AOX) in Drosophila Complements Defects in Mitochondrial Oxidative Phosphorylation
- (2009) Daniel J.M. Fernandez-Ayala et al. Cell Metabolism
- Use of Tris-hydroxymethyl aminomethane in severe lactic acidosis due to highly active antiretroviral therapy: a case report
- (2008) K. Marfo et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- The Variability of the Harlequin Mouse Phenotype Resembles that of Human Mitochondrial-Complex I-Deficiency Syndromes
- (2008) Paule Bénit et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started